People: Salix Pharmaceuticals Ltd (SLXP.OQ)

SLXP.OQ on NASDAQ Stock Exchange Global Select Market

131.81USD
11 Jul 2014
Price Change (% chg)

$-2.03 (-1.52%)
Prev Close
$133.84
Open
$133.28
Day's High
$134.57
Day's Low
$131.25
Volume
321,896
Avg. Vol
358,020
52-wk High
$141.28
52-wk Low
$65.00

Search Stocks

Derbyshire, Adam 

Brief Biography

Mr. Adam C. Derbyshire is Chief Financial Officer, Executive Vice President - Finance and Administration of Salix Pharmaceuticals Ltd. Mr. Derbyshire previously served as Senior Vice President, Finance and Administration and Chief Financial Officer from June 2003 to January 2009 and as Vice President, Finance and Administration and Chief Financial Officer from June 2000 to June 2003. From June 1999 to June 2000, Mr. Derbyshire was Vice President, Corporate Controller and Secretary of Medco Research, Inc., acquired by King Pharmaceuticals, Inc. in February 2000, Corporate Controller and Secretary of Medco from September 1995 to June 1999 and Assistant Controller of Medco from October 1993 to September 1995. Mr. Derbyshire received his B.S. degree from the University of North Carolina at Wilmington and his MBA from the University of North Carolina at Charlotte.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
488,866 -- 361,824 2,039,990

Options Compensation

  Quantity Market Value
Exercisable 320,000 3,735,000.00
Unexercisable 93,128 682,029.00
Exercised 120,000 4,388,930.00
Name Fiscal Year Total

Thomas D'Alonzo

--

Carolyn Logan

6,600,960

Adam Derbyshire

2,039,990

William Forbes

1,968,770

Rick Scruggs

1,802,050

John Chappell

--
As Of 30 Dec 2013
Search Stocks